Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9.
about
Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsTherapeutic targeting of replicative immortalityCyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cellsProtection after stroke: cellular effectors of neurovascular unit integrity.Cyclin-dependent kinase 9 may as a novel target in downregulating the atherosclerosis inflammation (Review).Trisubstituted pyrazolopyrimidines as novel angiogenesis inhibitors.Haemanthus coccineus extract and its main bioactive component narciclasine display profound anti-inflammatory activities in vitro and in vivoCyclin Dependent Kinase 9 Inhibitors for Cancer TherapyModulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma.Genetic and pharmacological inhibition of CDK9 drives neutrophil apoptosis to resolve inflammation in zebrafish in vivo.Effects of Cyclin Dependent Kinase 9 inhibition on zebrafish larvaePerspective of cyclin-dependent kinase 9 (CDK9) as a drug target.Identification of novel inhibitors against Cyclin Dependent Kinase 9/Cyclin T1 complex as: Anti cancer agent.In vitro and in vivo anti-tumor and anti-inflammatory capabilities of the novel GSK3 and CKD9 inhibitor ABC1183.
P2860
Q26827580-6F5496CD-1EAD-4712-9172-3A9F0C7BF6C1Q27027457-B303ED40-8BD8-4D57-BE13-CFA597C5B50EQ30654792-EA6637EC-C553-4ED1-B42F-171DC9C4E032Q34043168-F249184F-4570-4305-B2B1-25D0FE8AF64FQ34265421-13D15FA8-8983-4C7A-B7AF-0CCCA79758ADQ34555921-E1237048-BCD3-49AB-AC99-6962ED0E5CF5Q35571926-E0F729EF-0107-45B2-97FE-C622FE6C6081Q36015334-1F8918FF-F0CD-4A68-974F-2556DF3C5F69Q36709312-6180B952-C8E6-4884-8CA4-639FB21BF633Q37317180-814B1FD7-9B57-4213-AAB9-B69632CFF632Q37408454-1A1B09D0-8F6B-48E5-BC33-CD1065C8602BQ37467587-BB623453-B1F3-4EF4-BB73-4A3B4ED6D590Q38008733-AB5DF22C-37BE-4DF8-A0BC-84C68C4D4B04Q41457054-CF0B4504-516F-4107-AC2A-8FD7BBD05823Q50056226-C720C9D8-EBB0-4D0B-B107-DBC81420D1B5
P2860
Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Roscovitine blocks leukocyte e ...... lin-dependent kinases 5 and 9.
@en
Roscovitine blocks leukocyte e ...... lin-dependent kinases 5 and 9.
@nl
type
label
Roscovitine blocks leukocyte e ...... lin-dependent kinases 5 and 9.
@en
Roscovitine blocks leukocyte e ...... lin-dependent kinases 5 and 9.
@nl
prefLabel
Roscovitine blocks leukocyte e ...... lin-dependent kinases 5 and 9.
@en
Roscovitine blocks leukocyte e ...... lin-dependent kinases 5 and 9.
@nl
P2093
P2860
P1476
Roscovitine blocks leukocyte e ...... lin-dependent kinases 5 and 9.
@en
P2093
Angelika M Vollmar
Bettina A Mayer
Christoph A Reichel
Fritz Krombach
Nina Berberich
Robert Fürst
Ulrike K Schmerwitz
P2860
P304
P356
10.1111/J.1476-5381.2011.01309.X
P407
P577
2011-07-01T00:00:00Z